Seres Therapeutics, Inc. (NASDAQ:MCRB) Q1 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. My name is Desiree, and I will be your conference operator today.
Seres Therapeutics Inc. (MCRB)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Lion Point Didric Cederholm | 17,038.05 | $238,533 | 1.52% | |
| 2. | Tang Capital Management Kevin C. Tang | 10,195.2 | $142,753 | 0.01% | |
| 3. | Tudor Investment Corp Paul Tudor Jones | 3,098.85 | $43,390 | 0% | |
| 4. | Schonfeld Strategic Advisors Ryan Tolkin (Cio) | 2,565 | $35,915 | -50% | 0% |
| 5. | Engineers Gate Manager Greg Eisner | 2,381.85 | $33,351 | -44% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.15 | 5,825,495 | $18,350,309.25 | 5,825,495 | 2022-07-05 | Filing | |
| $3.15 | 2,912,748 | $9,175,156.20 | 5,875,711 | 2022-07-05 | Filing | |
| $2.25 | 4,444,444 | $9,999,999.00 | 4,444,444 | 2019-06-18 | Filing | |
| $2.25 | 4,444,444 | $9,999,999.00 | 4,444,444 | 2019-06-18 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.28 | 63 | $458.64 | 5,044 | 2025-05-16 | Filing | |
| $7.28 | 220 | $1,601.60 | 10,102 | 2025-05-16 | Filing | |
| $7.28 | 79 | $575.12 | 7,287 | 2025-05-15 | Filing | |
| $7.28 | 77 | $560.56 | 4,383 | 2025-05-16 | Filing | |
| $0.81 | 3,338 | $2,704.45 | 97,536 | 2025-02-18 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,155,852.25 | $16,184,242 | 6.86% | |
| 2. | 1,094,471.6 | $15,324,791 | 0% | |
| 3. | 304,599.95 | $4,264,399 | 0% | |
| 4. | 88,107.85 | $1,233,686 | 0% | |
| 5. | 80,938.6 | $1,133,667 | 0% |
News See All
Seres Therapeutics, Inc. (NASDAQ:MCRB) Q4 2024 Earnings Call Transcript
Operator: Thank you for standing by. My name is Kate, and I will be your conference operator today.
Seres Therapeutics, Inc. (NASDAQ:MCRB) Q3 2024 Earnings Call Transcript
Operator: Thank you for standing by. My name is Bella, and I will be your conference operator today.
Seres Therapeutics, Inc. (NASDAQ:MCRB) Q2 2024 Earnings Call Transcript
Operator: Good day, and thank you for standing by. At this time, I would like to welcome everyone to Seres Therapeutics Second Quarter 2024 Earnings Conference Call.
Seres Therapeutics, Inc. (NASDAQ:MCRB) Q1 2024 Earnings Call Transcript
Operator: Thank you for standing by. My name is Alex, and I will be your conference operator today.
11 Oversold NASDAQ Stocks To Buy Right Now
In this article, we will be taking a look at 11 oversold NASDAQ stocks to buy right now.
11 Oversold Healthcare Stocks To Buy Right Now
In this article, we will be taking a look at 11 oversold healthcare stocks to buy right now.
Seres Therapeutics, Inc. (NASDAQ:MCRB) Q4 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, good morning. My name is Abby, and will be your conference operator today.
Seres Therapeutics, Inc. (NASDAQ:MCRB) Q3 2023 Earnings Call Transcript
Operator: Welcome to the Seres Therapeutics Third Quarter 2023 Financial Results Conference Call. [Operator Instructions] Please note, this event is being recorded.
Seres Therapeutics, Inc. (NASDAQ:MCRB) Q2 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. My name is Desiree, and I will be your conference operator today.
Billionaire Hedge Funds
